Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis (Q43665831)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 April 2008

Language	Label	Description	Also known as
English	Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis	scientific article published on 10 April 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

0 references

author name string

Julio Morales

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

José Juan Martínez

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Karen Manoutcharian

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Marisela Hernández

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Agnes Fleury

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Goar Gevorkian

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Gonzalo Acero

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Abel Blancas

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Andrea Toledo

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Jacquelynne Cervantes

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Victor Maza

11

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Fabrice Quet

12

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Henri Bonnabau

13

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Aline S de Aluja

14

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Gladis Fragoso

15

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Carlos Larralde

16

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Edda Sciutto

17

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

10 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

2899-2905

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Taenia solium: the complex interactions, of biological, social, geographical and commercial factors, involved in the transmission dynamics of pig cysticercosis in highly endemic areas

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Epidemiological study of Taenia solium taeniasis/cysticercosis in a rural village in Yucatan state, Mexico

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

An epidemiological study of familial neurocysticercosis in an endemic Mexican community

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Taeniasis-cysticercosis in Southern Ecuador: assessment of infection status using multiple laboratory diagnostic tools

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Epidemiology and aetiology of epilepsy in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Epidemiology of neurocysticercosis in Houston, Texas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Deaths from cysticercosis, United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Control of Taenia solium taeniasis/cysticercosis: from research towards implementation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Treatment of neurocysticercosis: current status and future research needs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Development of an enzyme-linked immunoelectrotransfer blot (EITB) assay using two baculovirus expressed recombinant antigens for diagnosis of Taenia solium taeniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Advances in the diagnosis and management of neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

IL-1 resets glucose homeostasis at central levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Further evaluation of the synthetic peptide vaccine S3Pvac against Taenia solium cysticercosis in pigs in an endemic town of Mexico

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Threshold quantities for helminth infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

The role of sex steroids in the complex physiology of the host-parasite relationship: the case of the larval cestode of Taenia crassiceps

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Castration and pregnancy of rural pigs significantly increase the prevalence of naturally acquired Taenia solium cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Impact of naturally acquired Taenia solium cysticercosis on the hormonal levels of free ranging boars

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Sex-related severity of inflammation in parenchymal brain cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Deciphering western blots of tapeworm antigens (Taenia solium, Echinococcus granulosus, and Taenia crassiceps) reacting with sera from neurocysticercosis and hydatid disease patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.042

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.03.042

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43665831&oldid=2102389636"